Eli Lilly vs Novo Nordisk A S
LLY and NVO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LLY and NVO compare
Eli Lilly grew revenue faster over the last twelve months (45.5% versus 6.4% for Novo Nordisk A S).
Eli Lilly pays a dividend yielding 0.47%; Novo Nordisk A S does not pay one.
Eli Lilly scores higher on the StockData Score (20 against 4 for Novo Nordisk A S), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LLY | NVO |
|---|---|---|
| Size and price | ||
| Market cap | $1.3T | – |
| Share price | $1417.54 | $40.00 |
| Change, 1 year | 74.2% | −22.1% |
| Change, 5 years | 435% | −29.5% |
| Beta (5Y) | 0.52 | 0.76 |
| Employees | 50K | 70K |
| StockData Score | ||
| Total score | 20 (better) | 4 |
| Valuation score | 2 (better) | 0 |
| Growth score | 6 (better) | 2 |
| Performance score | 5 (better) | 0 |
| Health score | 4 (better) | 2 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 46.0× | – |
| P/S | 15.4× | – |
| P/B | 33.1× | – |
| EV/EBITDA | 37.3× | – |
| PEG | 0.93 | – |
| Fair value | $1125.50 | – |
| Margin of safety | −25.9% | – |
| Growth | ||
| Revenue growth (TTM) | 45.5% (better) | 6.4% |
| Revenue growth, 5Y average | 21.6% (better) | 19.5% |
| Net income growth (TTM) | 49.8% | – |
| EPS growth (TTM) | 50.7% (better) | 1.8% |
| EPS growth, 5Y average | 27.6% (better) | 20.7% |
| Profitability | ||
| Gross margin | 83.6% (better) | 81.0% |
| Operating margin | – | 41.3% |
| Net margin | 31.9% | – |
| FCF margin | – | 19.1% |
| Return on equity | 86.1% | – |
| Financial health | ||
| Debt / equity | 1.23 | – |
| Net debt / EBITDA | 1.21 | 0.82 (better) |
| Interest coverage | – | 18.8× |
| Current ratio | 1.39 (better) | 0.80 |
| Altman Z-score | 8.52 | – |
| Piotroski F-score | 7 | – |
| Dividends and buybacks | ||
| Dividend yield | 0.47% | – |
| Payout ratio | 21.7% | – |
| Years of dividend growth | 9 | – |
| Dividend growth, 5Y average | 15.2% | – |
| Buyback yield | 0.44% | – |
| Shareholder yield | 0.91% | – |
| Ownership | ||
| Held by institutions | 83.7% | 7.3% |
| Held by insiders | 10.4% | 0.00% |
| Insider net buying, 12 months | −$2.3B | – |
| Superinvestors holding | 3 (better) | 1 |
| Short interest, % of float | 0.83% | – |
Go deeper
- LLY stock overview
- LLY income statement
- LLY valuation and score
- NVO stock overview
- NVO income statement
- NVO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.